Biography
Professor Ben Solomon is a medical oncologist in the Lung Service and the Head & Neck service. He is the Group Leader of the Molecular Therapeutics and Biomarkers Laboratory in the Research Division. He has an interest in translational lung cancer research and completed a PhD investigating the mechanisms by which EGFR inhibition enhance the effects of radiation, and subsequent postdoctoral studies at the University of Colorado investigating novel predictive markers for therapy with EGFR inhibitors.
Professor Solomon returned to Peter Mac in 2006, where he now practices as a medical oncologist with a research focus on clinical and translational research in lung cancer and head and neck cancer. His clinical trial work focuses on the identification of novel therapies for lung cancer. The Molecular Therapeutics and Biomarkers Laboratory focuses on pre-clinical studies of novel therapies for cancer and, more specifically, identification of prognostic and predictive biomarkers in lung and head and neck cancers.
